1. Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report. Issue 3 (March 2016) Authors: Nonagase, Yoshikane; Okamoto, Kunio; Iwasa, Tsutomu; Yoshida, Takeshi; Tanaka, Kaoru; Takeda, Masayuki; Kaneda, Hiroyasu; Shimizu, Toshio; Tsurutani, Junji; Nakagawa, Kazuhiko Journal: Anti-cancer drugs Issue: Volume 27:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinoma. Issue 16 (8th July 2022) Authors: Nakahama, Kenji; Kaneda, Hiroyasu; Osawa, Masahiko; Izumi, Motohiro; Yoshimoto, Naoki; Sugimoto, Akira; Nagamine, Hiroaki; Ogawa, Koichi; Matsumoto, Yoshiya; Sawa, Kenji; Tani, Yoko; Mitsuoka, Shigeki; Watanabe, Tetsuya; Asai, Kazuhisa; Kawaguchi, Tomoya Journal: Thoracic cancer Issue: Volume 13:Issue 16(2022) Page Start: 2309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan. Issue 9 (9th September 2020) Authors: Ogawa, Koichi; Koh, Yasuhiro; Kaneda, Hiroyasu; Izumi, Motohiro; Matsumoto, Yoshiya; Sawa, Kenji; Fukui, Mitsuru; Taniguchi, Yoshihiko; Yoshimoto, Naoki; Tamiya, Akihiro; Ando, Masahiko; Kubo, Akihito; Isa, Shun-ichi; Saka, Hideo; Matsumura, Akihide; Kawaguchi, Tomoya Journal: BMJ open Issue: Volume 10:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation. (November 2016) Authors: Tanizaki, Junko; Banno, Eri; Togashi, Yosuke; Hayashi, Hidetoshi; Sakai, Kazuko; Takeda, Masayuki; Kaneda, Hiroyasu; Nishio, Kazuto; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 101(2016) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation. (November 2016) Authors: Tanizaki, Junko; Banno, Eri; Togashi, Yosuke; Hayashi, Hidetoshi; Sakai, Kazuko; Takeda, Masayuki; Kaneda, Hiroyasu; Nishio, Kazuto; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 101(2016) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Issue 11 (November 2016) Authors: Hibi, Masaaki; Kaneda, Hiroyasu; Tanizaki, Junko; Sakai, Kazuko; Togashi, Yosuke; Terashima, Masato; De Velasco, Marco Antonio; Fujita, Yoshihiko; Banno, Eri; Nakamura, Yu; Takeda, Masayuki; Ito, Akihiko; Mitsudomi, Tetsuya; Nakagawa, Kazuhiko; Okamoto, Isamu; Nishio, Kazuto Journal: Cancer science Issue: Volume 107:Issue 11(2016) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR‐mutant non‐small cell lung cancer. Issue 10 (30th August 2019) Authors: Matsumoto, Yoshiya; Sawa, Kenji; Fukui, Mitsuru; Oyanagi, Jun; Izumi, Motohiro; Ogawa, Koichi; Suzumura, Tomohiro; Watanabe, Tetsuya; Kaneda, Hiroyasu; Mitsuoka, Shigeki; Asai, Kazuhisa; Kimura, Tatsuo; Yamamoto, Nobuyuki; Koh, Yasuhiro; Kawaguchi, Tomoya Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial. Issue 16 (December 2015) Authors: Shukuya, Takehito; Yamanaka, Takeharu; Seto, Takashi; Daga, Haruko; Goto, Koichi; Saka, Hideo; Sugawara, Shunichi; Takahashi, Toshiaki; Yokota, Soichiro; Kaneda, Hiroyasu; Kawaguchi, Tomoya; Nagase, Seisuke; Oguri, Tetsuya; Iwamoto, Yasuo; Nishimura, Takashi; Hattori, Yoshihiro; Nakagawa, Kazuhik... Journal: Lancet oncology Issue: Volume 16:Issue 16(2015) Page Start: 1630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase 2 study of S‐1 and carboplatin plus bevacizumab followed by maintenance S‐1 and bevacizumab for chemotherapy‐naive patients with advanced nonsquamous non–small cell lung cancer. Issue 12 (4th April 2013) Authors: Urata, Yoshiko; Okamoto, Isamu; Takeda, Masayuki; Hattori, Yoshihiro; Okuno, Keiko; Shimada, Temiko; Kurata, Takayasu; Kaneda, Hiroyasu; Miyazaki, Masaki; Terashima, Masaaki; Tanaka, Kaoru; Morita, Satoshi; Nakagawa, Kazuhiko; Negoro, Shunichi; Satouchi, Miyako Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase 2 study of S‐1 and carboplatin plus bevacizumab followed by maintenance S‐1 and bevacizumab for chemotherapy‐naive patients with advanced nonsquamous non–small cell lung cancer. Issue 12 (4th April 2013) Authors: Urata, Yoshiko; Okamoto, Isamu; Takeda, Masayuki; Hattori, Yoshihiro; Okuno, Keiko; Shimada, Temiko; Kurata, Takayasu; Kaneda, Hiroyasu; Miyazaki, Masaki; Terashima, Masaaki; Tanaka, Kaoru; Morita, Satoshi; Nakagawa, Kazuhiko; Negoro, Shunichi; Satouchi, Miyako Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗